Literature DB >> 34216268

Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.

Hamid Heidarian Miri1, Pooria Fazeli2, Mohammad Ali-Hassanzadeh3, Peyman Bemani4, Dieter Kabelitz5, Kurosh Kalantar6.   

Abstract

Hepatitis C virus (HCV) is a serious global health issue. Nearly 20% of HCV patients spontaneously clear the virus. While some studies have shown an association of spontaneous clearance (SC) of the virus with interleukin (IL) 28B single-nucleotide polymorphisms (SNPs), others did not show such a relationship. Thus, the purpose of the present study was to investigate the association of IL28B polymorphisms (12979860 SNP) with SC of HCV infection. Upon initial screening of the databases, a total of 545 articles were retrieved, of which 22 studies that met predefined eligibility criteria were entered into the meta-analysis. Odds ratios (ORs) with confidence intervals (95% CI), heterogeneity, publication bias, and sensitivity analysis were assessed. According to the meta-analysis results, a significant association was observed between the rs12979860 SNP and SC of HCV infection. The results indicated that the ORs of SC from hepatitis C virus infection were 2.75 times higher in those with cytokine gene polymorphisms (95% CI, 2.23 to 3.38). Moreover, it was found that the prevalence of rs12979860 CC was 0.33 with 95 CI 0.28-0.38 in genotype 1 and was 0.40 with 95 CI 0.34-0.47 in other genotypes. Our meta-analysis results suggest that IL28B rs12979860 CC is a strong predictor for SC of hepatitis C infection in PEG IFN-a/RBV-treated patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Year:  2021        PMID: 34216268     DOI: 10.1007/s00705-021-05141-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  60 in total

1.  Discovery of critical host factor, IL-28B, associated with response to hepatitis C virus treatment.

Authors:  Masashi Mizokami
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

Review 2.  Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.

Authors:  Philippe Georgel; Catherine Schuster; Mirjam B Zeisel; Françoise Stoll-Keller; Thomas Berg; Seiamak Bahram; Thomas F Baumert
Journal:  Trends Mol Med       Date:  2010-05-25       Impact factor: 11.951

Review 3.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

4.  Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.

Authors:  Joop E Arends; Justin H Fransen; Andy I M Hoepelman; Debbie van Baarle
Journal:  Int J Antimicrob Agents       Date:  2011-10-04       Impact factor: 5.283

Review 5.  Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.

Authors:  Andrew R Lloyd; Emma Jagger; Jeffrey J Post; Lee-Ann Crooks; William D Rawlinson; Young S Hahn; Rosemary A Ffrench
Journal:  Immunol Cell Biol       Date:  2006-11-28       Impact factor: 5.126

Review 6.  Hepatitis C virus: A global view.

Authors:  Amal Ahmed Mohamed; Tamer A Elbedewy; Magdy El-Serafy; Naglaa El-Toukhy; Wesam Ahmed; Zaniab Ali El Din
Journal:  World J Hepatol       Date:  2015-11-18

Review 7.  Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

Authors:  Khayriyyah Mohd Hanafiah; Justina Groeger; Abraham D Flaxman; Steven T Wiersma
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

8.  Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.

Authors:  María A Jiménez-Sousa; Amanda Fernández-Rodríguez; María Guzmán-Fulgencio; Mónica García-Álvarez; Salvador Resino
Journal:  BMC Med       Date:  2013-01-08       Impact factor: 8.775

Review 9.  Host factors determining the efficacy of hepatitis C treatment.

Authors:  Wan-Long Chuang; Ming-Lung Yu
Journal:  J Gastroenterol       Date:  2012-10-27       Impact factor: 7.527

Review 10.  Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.

Authors:  Arnolfo Petruzziello; Samantha Marigliano; Giovanna Loquercio; Anna Cozzolino; Carmela Cacciapuoti
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.